期刊文献+

奇正消痛贴膏提取物对脂多糖诱导的巨噬细胞一氧化氮及其诱导型合酶的影响 被引量:3

Effects of extracts of Cheezheng pain relieving plaster on nitric oxide and iNOS expression in macrophages induced by lipopolysaccharides
原文传递
导出
摘要 考察奇正消痛贴膏提取物(extracts of Cheezheng pain relieving plaster,ECPRP)对巨噬细胞一氧化氮的生成及诱导型一氧化氮合酶表达的影响,并探讨其作用机制。采用Griess试剂检测培养上清液中NO2-的含量,RT-PCR法测定LPS刺激的小鼠腹腔巨噬细胞中iNOSmRNA的表达,Western blotting法测定其iNOS蛋白的表达和NF-κB的活化情况。结果显示,ECPRP(62.5和125mg·L-1)可显著抑制巨噬细胞NO的生成以及LPS引起的iNOS mRNA和蛋白表达的增加;并可抑制I-κB在细胞浆内的降解以及NF-κBp65向胞核内的转位、阻止其活化。因此,ECPRP的抗炎作用机制之一可能是通过抑制巨噬细胞NF-κB的活性,从而降低巨噬细胞iNOSmRNA和蛋白的表达、减少NO的生成。 This study is to explore the effects of extracts of Cheezheng pain relieving plaster (ECPRP) on nitric oxide (NO) production and expression of inducible nitric oxide synthase (iNOS) in macrophages induced by LPS and the mechanism involved. Nitric oxide level was measured with Griess reagent assay. Inducible nitric oxide synthase (iNOS) protein and NF-κBp65 fragment were detected with Western blotting. ECPRP (62.5 and 125 mg·L^-1) significantly inhibited the increase of nitric oxide level. Furthermore, ECPRP (62.5 and 125 mg·L^-1) notably reduced the expression of iNOS mRNA and protein. ECPRP (62.5 and 125 mg·L^-1) elevated the content of I-κB protein in cytoplasm, while decreased the content of NF-κBp65 protein in nucleus. These results suggest that ECPRP reduce nitric oxide level via down-regulation of NF-κB-iNOS-nitric oxide pathway, resulting in prevention of inflammation.
出处 《药学学报》 CAS CSCD 北大核心 2009年第8期863-867,共5页 Acta Pharmaceutica Sinica
基金 国家科技支撑计划资助项目(2007BAI31B04)
关键词 奇正消痛贴膏 一氧化氮 诱导型一氧化氮合酶 核因子-ΚB 巨噬细胞 Cheezheng pain relieving plaster nitric oxide inducible nitric oxide synthase nuclear factorκB macrophage
  • 相关文献

参考文献10

  • 1Huskisson EC, Berry H, Gishen P, et al. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal investigation of nonsteroidal anti-inflammatory drugs in knee osteoarthritis [J]. J Rheumatol, 1995, 22: 1941-1946.
  • 2Cheezheng Tibetan Medicine Co Ltd. A Tibetan medicine for treatment of acute and chronic twisting injury and rheumatic or rheumatoid disease and its preparation methods: China, 200510080696.4 [P]. 2005-12-21.
  • 3DongFH.The clinical research on Qizhengxiaotongtiegao treating arthritis .继续医学教育,2005,7:82-86.
  • 4HaoSL.The Clinical research on Qizhengxiaotongtiegao treating scapulohumeral periarthritis .中医正骨,2005,17:13-14.
  • 5GaoY NiT WuLY etal.Experimental study on treatment of soft tissue injuries with Qizhengxiaotongtiegao therapy .中国中医骨科杂志,2006,14:31-31.
  • 6XuRM ZhangSR ZhangYS.Study on Qizhengxiaotongtiefen in anti-inflammation and analgesia .中华中西医杂志,2004,5:15-17.
  • 7Grabowski PS, Wright PK, Van't Hof RJ, et al. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis [J]. Br J Rheumatol, 1997, 36: 651-655.
  • 8Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis [J]. Arthritis Res Ther, 2008, 10 Suppl 2: S2.
  • 9Pelletier JP, Jovanovic D, Julio C. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase [J]. Arthritis Rheum, 1998, 41: 175-186.
  • 10Oh JH, Lee TJ, Park JW, et al. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells [J]. Eur J Pharmacol, 2008, 599: 11-17.

同被引文献94

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部